ACR Joins Coalition Opposing Proposed H-1B Visa Fee
ACR joins healthcare groups opposing a proposed H-1B visa fee increase that could worsen physician shortages and limit patient access.
Read moreThe U.S. House of Representatives voted Dec. 16, to advance the Women and Lung Cancer Research and Preventive Services Act of 2024 (H.R. 4534), legislation supported by the American College of Radiology® (ACR®). The bipartisan bill would require the U.S. Department of Health and Human Services, in conjunction with the Departments of Defense and Veterans Affairs, to conduct an interagency review to evaluate research on women and lung cancer. The review must: include a report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.
Introduced by Reps. Brendan Boyle (D-PA), Brian Fitzpatrick (R-PA), Lisa Blunt Rochester (D-DE), Derek Kilmer (D-WA), Salud Carbajal (D-CA), and Jamie Raskin (D-MD), H.R. 4534 was reported unanimously out of the House Committee on Energy and Commerce in June. While there is a Senate companion bill, S. 2245, it has not moved out of committee or been voted on. To become law, the Senate would have to vote in favor of the legislation as well before sending it to the president for signature.
If you have questions or would like more information, contact Ashley Walton, ACR Director of Government Affairs.
ACR Joins Coalition Opposing Proposed H-1B Visa Fee
ACR joins healthcare groups opposing a proposed H-1B visa fee increase that could worsen physician shortages and limit patient access.
Read moreACR Collaborates on 14 Action Plans at AMA RUC Meeting
ACR participated in the September AMA RUC meeting, presenting 14 multispecialty action plans and advancing radiology priorities
Read moreState Legislative Action on Breast Health Bills in 2026
From cost-sharing reforms to expanded screening access, explore key breast health legislation enacted across states in 2026.
Read more